These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 33090233)

  • 1. Choroidal Neovascular Membrane in a Teenage Girl With Chronic Intracranial Hypertension.
    Krompas I; Kouri A; Gotzaridis S; Georgalas I; Kandarakis S; Petrou P
    J Pediatr Ophthalmol Strabismus; 2020 Oct; 57():e86-e87. PubMed ID: 33090233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal Ranibizumab Injection in Peripapillary CNVM Related to Idiopathic Intracranial Hypertension.
    Altan-Yaycioglu R; Canan H; Saygi S
    J Pediatr Ophthalmol Strabismus; 2017 Apr; 54():e27-e30. PubMed ID: 28453165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful management of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab.
    Kumar N; Tigari B; Dogra M; Singh R
    Indian J Ophthalmol; 2018 Sep; 66(9):1358-1360. PubMed ID: 30127172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juxtapapillary neovascular membrane secondary to idiopathic intracranial hypertension treated with intravitreal bevacizumab: A case report.
    Hernández-Ortega V; Soler-Sanchís MI; Jiménez-Escribano RM; Sanz-López AM
    Arch Soc Esp Oftalmol; 2016 May; 91(5):250-4. PubMed ID: 26832628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab in the treatment of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension.
    Lee IJ; Maccheron LJ; Kwan AS
    J Neuroophthalmol; 2013 Jun; 33(2):155-7. PubMed ID: 23235432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INFLAMMATORY CHOROIDAL NEOVASCULAR MEMBRANE: Long-Term Visual and Anatomical Outcomes After Intravitreal Anti-vascular Endothelial Growth Factor Therapy.
    Dʼsouza P; Ranjan R; Babu U; Kanakath AV; Saravanan VR
    Retina; 2018 Jul; 38(7):1307-1315. PubMed ID: 28520642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab.
    Saitta A; Nicolai M; Neri P; Reibaldi M; Giovannini A; Mariotti C
    Int Ophthalmol; 2015 Jun; 35(3):441-4. PubMed ID: 25761547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal Administration of Ranibizumab and Bevacizumab for Choroidal Neovascularization Secondary to Ocular Toxocariasis: A Case Report.
    Yoon DY; Woo SJ
    Ocul Immunol Inflamm; 2018; 26(4):639-641. PubMed ID: 27775459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Choroidal Neovascular Membranes Associated with Choroidal Nevi.
    Munie MT; Demirci H
    Ophthalmol Retina; 2018 Jan; 2(1):53-58. PubMed ID: 31047303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal ranibizumab and bevacizumab therapy for choroidal neovascularization in age-related macular degeneration with extensive pre-existing geographic atrophy.
    Amaro MH; Roller AB
    Arq Bras Oftalmol; 2012; 75(4):273-6. PubMed ID: 23258660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Follow-Up of Choroidal Neovascularization due to Angioid Streaks with pro re nata Intravitreal Anti-VEGF Treatment.
    Giacomelli G; Finocchio L; Biagini I; Sodi A; Murro V; Introini U; Varano M; Bandello F; Menchini U
    Ophthalmologica; 2017; 238(1-2):44-51. PubMed ID: 28641290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy.
    Barth T; Zeman F; Helbig H; Gamulescu MA
    Int Ophthalmol; 2018 Jun; 38(3):923-931. PubMed ID: 28424992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Peripapillary Choroidal Neovascular Membrane in Patients With Idiopathic Intracranial Hypertension.
    Ozgonul C; Moinuddin O; Munie M; Lee MS; Bhatti MT; Landau K; Van Stavern GP; Mackay DD; Lebas M; DeLott LB; Cornblath WT; Besirli CG
    J Neuroophthalmol; 2019 Dec; 39(4):451-457. PubMed ID: 30951011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
    Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of efficacy and recurrence for anti-vascular endothelial growth factor therapy in idiopathic choroidal neovascularization.
    Wu Q; Chen X; Feng K; Liu Y; Zhang C; Zhao L
    BMC Ophthalmol; 2020 Mar; 20(1):115. PubMed ID: 32192468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA: SIX YEARS OUTCOME.
    Ruiz-Moreno JM; Montero JA; Araiz J; Arias L; García-Layana A; Carneiro A; Figueroa MS; Silva R
    Retina; 2015 Dec; 35(12):2450-6. PubMed ID: 26049616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual and optical coherence tomography outcomes of intravitreal bevacizumab and ranibizumab in inflammatory choroidal neovascularization secondary to punctate inner choroidopathy.
    Cornish KS; Williams GJ; Gavin MP; Imrie FR
    Eur J Ophthalmol; 2011; 21(4):440-5. PubMed ID: 21188681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to pseudotumor cerebri.
    Jamerson SC; Arunagiri G; Ellis BD; Leys MJ
    Int Ophthalmol; 2009 Jun; 29(3):183-5. PubMed ID: 18196206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress of treatment strategies for choroidal neovascularization secondary to pathological myopia].
    Shi XH; Wei WB
    Zhonghua Yan Ke Za Zhi; 2019 Oct; 55(10):791-795. PubMed ID: 31607068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence Rate of Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration Managed with a Treat-Extend-Stop Protocol.
    Adrean SD; Chaili S; Grant S; Pirouz A
    Ophthalmol Retina; 2018 Mar; 2(3):225-230. PubMed ID: 31047590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.